Emerging & Re-Emerging

 

 

The Ebola & Zika outbreaks brought emerging and re-emerging diseases screaming into the limelight. This brought with it a renewed vigor for vaccines from the public and a catalyst for the scientific community to progress vaccines for diseases such as Ebola, Malaria, Dengue, and Chikungunya. Use this Conference to meet with and demonstrate your knowledge to the organizations who are pushing forward in this area.

 

Who Attends

 

• Pharma
• Biotech
• National and International Government
• Non-Profit Organizations
• Academics And Research Institutions

 

Job Titles

 

• CEO / CSO / COO
• CMO / Head of Scientific Affairs
• Head of Infectious / Emerging / Neglected Disease
• Head of R&D
• Head of Virology
• Head of Immunology

Who Should Sponsor?

 

• Platform Technology Providers
• Logistics / Cold Chain
• Biotechs
• Big Pharma

 

 

Emerging and Re-emerging Diseases, Tuesday 16 April 2019

Emerging and Re-emerging Diseases
09:00

Chair's opening remarks

Ebola & Flavivirus Update

Nelson Michael
Emerging and Re-emerging Diseases
10:10

Executing multi-international trials and research for infectious diseases at WRAIR

10:40

Networking Coffee Break

Global Health Preparedness Strategy and Platform Technologies

Wolfgang Bender
Emerging and Re-emerging Diseases
11:40

Developing a single-shot vaccine against Chikungunya: VLA 1553 Phase 1 initial results and next steps

Dr Alexander Kort
Emerging and Re-emerging Diseases
12:10

Advancements towards first commercial Chikungunya vaccine

Senior representative, Nipah Project Leader, PATH
Mark Feinberg
Emerging and Re-emerging Diseases
12:25

Applying knowledge from HIV to develop a Lassa vaccine

Rerserved for IAVI
Dr Max Søgaard
Emerging and Re-emerging Diseases
12:55

ExpreS2 – An insect cell-based vaccine production system suitable for difficult-to-express proteins

13:10

Networking Lunch & Poster Session

Thomas Lingelbach
Emerging and Re-emerging Diseases
14:40

Towards a novel prophylactic vaccine for the prevention of Lyme disease: Development status and outlook

Intervention Trials for Aedes-Transmitted Diseases

Duane Gubler
16:10

Networking Coffee Break

Duane Gubler
Jason Ezzelle
Emerging and Re-emerging Diseases
17:40

Expeditionary research in emerging & re-emerging disease: What is it?

  • Accessing emerging / re-emerging diseases in difficult or remote regions of the world is immensely complex.
  • Learn what expeditionary research is and how to support it (staff, technology, logistics)
  • How do you switch from a briefcase to a backpack
18:10

Chair’s Closing Remarks per co-lo and Close of Congress Day 2

18:15

Off-site Networking Drinks, Supported by Enesi Pharma

last published: 11/Apr/19 17:05

 

Emerging and Re-emerging Diseases, Wednesday 17 April 2019

Emerging and Re-emerging Diseases
09:00

Chair's opening remarks

Eliminating Global Infectious Diseases

Emerging and Re-emerging Diseases
09:10

What the gates MRI are doing: TB, malaria, enteric

David Sack
Emerging and Re-emerging Diseases
10:10

Use of oral cholera vaccine as a key component to eliminate epidemic cholera as a public health threat

10:40

Networking Coffee Break

Carl Dieffenbach
Emerging and Re-emerging Diseases
11:30

The path to controlling the Global HIV pandemic; the roles of antiretrovirals and preventive vaccines

12:30

Networking Lunch & Poster Session

DAY 3 AFTERNOON PLENARY OF CONGRESS: RENAISSANCE BALLROOM

Paul Offit
13:40

New lessons from old controversies

  • What have we learnt from previous vaccines failures to drive new vaccines forward?
  • Why is there is low uptake on currently available vaccines? E.g. HPV & influenza
  • Examples and case studies from: Lyme & Rota – what does this mean for future vaccine innovation and R&D?
Dr Saad Omer
14:55

A framework for a comprehensive maternal immunization platform

  • Evidence for current immunization recommendations
  • Maternal vaccines in development
  • The need for evidence-based interventions at the practice, provider, and patient levels to ensure higher vaccination levels
Dr Timothy Cooke
16:00

Chair Closing Remarks and End of Congress

last published: 11/Apr/19 17:05

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071